Levonorgestrel/Ethinylestradiol Sandoz

Ethinylestradiol, the active ingredient in Levonorgestrel/Ethinylestradiol Sandoz, is a combined estrogen‑progestogen oral contraceptive presented as a tablet for oral use. It prevents pregnancy in women of reproductive age.

GNH USA supplies Levonorgestrel/Ethinylestradiol Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levonorgestrel/Ethinylestradiol is a combined estrogen‑progestogen oral contraceptive used in the hormonal birth‑control pathway.

- Prevention of pregnancy: provides reliable hormonal contraception for women of childbearing age. - Menstrual cycle regulation: helps achieve more predictable and regular periods. - Acne management: may improve moderate acne associated with hormonal fluctuations.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: temporary swelling or discomfort. - Headache: occasional mild to moderate pain. - Weight gain: slight increase due to fluid retention. - Mood changes: irritability or emotional fluctuations. - Breakthrough bleeding: spotting between periods.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in veins. - Pulmonary embolism: clot traveling to lungs. - Stroke: interruption of cerebral blood flow. - Myocardial infarction: heart attack risk. - Severe allergic reaction: rash, swelling, difficulty breathing. - Liver tumor: rare benign growths in the liver.

Before prescribing Levonorgestrel/Ethinylestradiol, clinicians should consider several safety factors. - Assess thrombotic risk: avoid use in women with history of clotting disorders. - Screen for hypertension: uncontrolled high blood pressure increases cardiovascular risk. - Avoid smoking: especially in women over 35 years of age. - Evaluate liver function: hepatic impairment may alter drug metabolism. - Pregnancy contraindication: do not start in women who are pregnant or suspect pregnancy. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Levonorgestrel/Ethinylestradiol may interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): reduce contraceptive efficacy. - Rifampin and other rifamycins: decrease hormone levels, increasing pregnancy risk. - St. John's wort: herbal inducer that lowers plasma concentrations.

Moderate Interactions (Monitor Closely): - Certain antibiotics (e.g., tetracycline, metronidazole): may slightly reduce effectiveness. - Antifungal agents (e.g., fluconazole): can increase hormone levels, raising side‑effect potential. - Protease inhibitor antiretrovirals: may require closer monitoring of contraceptive reliability.